85th Scientific Sessions of the American Diabetes Association (ADA) - Oral Presentation #272-OR
Jun 22, 2025 at 3:15 PM CDT
Title: COVALENT-111: 26-Week Efficacy and Safety after 8 and 12 Weeks of Daily Oral Icovamenib in Patients with Poorly Controlled Type 2 Diabetes